▶ As a leading company in Metaverse, it was recognized for its contribution to national and social development by developing medical virtual reality (VR) and augmented reality (AR) technologies.

MEDICAL IP received a commendation from the Ministry of Trade, Industry and Energy in recognition of its contribution to national social development through the promotion of virtual reality (VR) and augmented reality (AR) industries.

MEDICAL IP received a commendation from the Minister of Trade, Industry and Energy in recognition of its contribution to national social development through the promotion of virtual reality (VR) and augmented reality (AR) industries.

A company official said, "MEDICAL IP is developing virtual reality and augmented reality contents of human body information contained in actual patient's medical image data through AI technology that segments anatomical structures from medical image data, such as CT and MRI." Through this, all organ regions of the patient can be implemented on the metaverse.”

In practice, MEDICAL IP is leading a change in the medical paradigm by introducing the 'medical metaverse' technology that allows the patient's anatomical information to be checked on the metaverse.

MEDICAL IP applied metaverse technology to anatomical hands-on education at Seoul National University College of Medicine for the first time in Korea and introduced a solution that can replace cadaver used for existing practical education.

In addition, MEDICAL IP drew attention at RSNA 2021, North America's largest radiology conference recently held in Chicago, as the company first unveiled multiple medical metaverse solutions.

Besides, MEDICAL IP is continuously developing various solutions that can broaden the application of Metaverse in the medical field, for example, augmented reality technology that can be used as a navigation for neurosurgery.

Therefore, the company is leading the increase in medical education efficiency, improvement of surgical safety, and maximization of accuracy through cutting-edge technologies, such as virtual and augmented reality called metaverse.

Sang-Joon Park, the CEO of MEDICAL IP, said, “Medical Metaverse is a technology that can lead a paradigm shift in the entire medical cycle from image acquisition to utilization and further treatment, such as replacing cadavers for dissection and greatly improving the accuracy of actual surgery. With this opportunity, we will further devote ourselves to the advancement of medical metaverse technology.”